Close Menu
  • Home
  • Markets
    • Earnings
  • Banks
    • Crypto
    • Investing
  • Business
    • Retail
  • industry
    • Finance
    • Energy
    • Real Estate
  • Politics
  • Editorials
Facebook X (Twitter) Instagram
Facebook LinkedIn
Financial Market News
Subscribe Now
  • Home
  • Markets
    • Earnings
  • Banks
    • Crypto
    • Investing
  • Business
    • Retail
  • industry
    • Finance
    • Energy
    • Real Estate
  • Politics
  • Editorials
Financial Market News
You are at:Home»Posts Tagged "drug"

China’s Rise in Drug Development Looms Over U.S.

By FinMar NewsMay 30, 2026

Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the…

Replimune to resubmit melanoma drug after FDA’s Makary leaves

By FinMar NewsMay 29, 2026

Thomas Fuller | Lightrocket | Getty ImagesReplimune plans to resubmit its melanoma drug to the Food and Drug Administration for review after a leadership exodus at…

FDA Commissioner Marty Makary defends Replimune drug approval decision

By FinMar NewsMay 5, 2026

Martin Makary, commissioner of the Food and Drug Administration (FDA), during a news conference at the US Food and Drug Administration headquarters in Silver Spring, Maryland,…

Restaurants add protein, fiber for weight loss drug users

By FinMar NewsMarch 23, 2026

A mini burger, mini fries and mini beer, Clinton Hall’s “Teeny Weeny Mini Meal”, is pictured next to a regular-sized combo on Dec. 8, 2025 in…

FDA approves high dose version of Novo Nordisk’s obesity drug Wegovy

By FinMar NewsMarch 19, 2026

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4, 2026.Tom Little | ReutersThe Food and…

Big Pharma is ready for its AI drug investments to pay off

By FinMar NewsJanuary 4, 2026

Optimism for AI-powered drug discovery is rising as industry giants, startups, and even Sam Altman step up investments Read More: Big Pharma is ready for its…

Novo Nordisk shares fall after Alzheimer’s drug trial fails to hit target

By FinMar NewsNovember 24, 2025

The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, Nov. 5, 2025. Nichlas Pollier | Bloomberg | Getty ImagesShares of Novo Nordisk on Monday fell…

What’s next for the weight loss drug market: pills, rivals, insurance

By FinMar NewsNovember 2, 2025

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | ReutersThe…

Trump reaches drug pricing deal with AstraZeneca

By FinMar NewsOctober 11, 2025

U.S. President Donald Trump participates in a bilateral meeting with Finland’s President Alexander Stubb (not pictured), in the Oval office at the White House in Washington,…

Medicare drug price negotiations list includes Ozempic

By FinMar NewsJanuary 18, 2025

A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating Type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo,…

1 2 3 Next
Energy News

Energy Costs Divide Curry, Otis at Climate Forum | News

Brent, WTI, Saudi Arabia, Houthi

The Iran war is driving clean energy development. It’s not enough to help

Transport companies sound alarm on skyrocketing fuel prices amid Iran war

Banks News

NBK launches ‘NBK Reach’ for Kuwaiti students in UK

Industry moves: Wellington-Altus adds Saint John advisor team

Bank of England holds interest rates – industry reaction

Maybank, Asian Banking School collaborate on wealth advisory certification

Real Estate News

SC law needs clarity on when apartments get a tax break

Law firm tees up class action linked to MRED-Compass deal

Is Cuba Trump’s next real estate project? : Code Switch : NPR

Pending Home Sales Are the Real Leading Signal — Contracts Already Softened

© 2026 finmar.news

Type above and press Enter to search. Press Esc to cancel.

Social Media Auto Publish Powered By : XYZScripts.com